Merck indicates launch/pricing plans for Victrelis in Europe
This article was originally published in Scrip
Executive Summary
Following the EU approval of Victrelis (boceprevir), Merck has told Scrip that the first launches for the product in Europe are likely to be in the UK, Denmark, France, Germany and Sweden.